From January to February 2019, the retail sales of Chinese and Western medicines reached 93 billion yuan

[China Pharmaceutical network industry trends] according to the data of the National Bureau of statistics, from January to February 2019, the total retail sales of social consumer goods reached 6606.4 billion yuan, a year-on-year nominal increase of 8.2% Among them, the retail sales of Chinese and Western medicines reached 93 billion yuan, an increase of 10.3% compared with the same period last year According to the analysis of the industry, this is mainly because the influenza factor in the beginning of 2019 has driven the hot sales of anti infective drugs, especially brought new opportunities to the cold medicine market with relatively stable sales growth of retail pharmacies For example, during the period of influenza, the health care Commission issued the influenza diagnosis and treatment plan (revised version in 2018) Oseltamivir (capsules / granules), zanamivir, palamivir, as well as some traditional Chinese medicine products commonly used for wind heat invading the health, clearing away heat and detoxification, promoting lung and stopping cough are regarded as the recommended anti influenza drugs With the advent of influenza, these drugs will also usher in the peak season of sales and expand the market scale According to the 2017 statistical analysis report on the operation of drug circulation industry issued by the Ministry of Commerce, the overall scale of China's drug retail market reached 400.3 billion yuan in 2017 It is estimated that by 2020, the overall scale of China's drug retail market is expected to reach 520 billion yuan In addition, in the environment of medical insurance cost control and volume purchase, the "moisture" in the drug price, such as sales cost and marketing cost, is squeezed out, and the unit price of some drugs is reduced However, doctors may sell other high rebate drugs, such as Chinese patent medicine, which leads to the increase of demand for Chinese patent medicine and other drugs The industry also pointed out that with the deepening of medical reform, the combination of policies such as bidding, drug proportion and medical insurance payment, the trend of separation of medical industry and outflow of prescriptions is becoming more and more obvious Therefore, in the context of the continuous expansion of pilot volume procurement, it is inevitable for pharmaceutical enterprises to shift their sales focus to the outside of hospital, and the market for prescription outflow will blow out According to industry estimates, by 2020, the market share of prescription outflow can reach 400 billion yuan In the face of the huge market brought by the outflow of prescription, retail chain pharmacies, DTP pharmacies, pharmaceutical providers, Internet plus medical enterprises all seize the opportunity to actively layout Among them, retail chain drugstores are favored by the industry, while DTP drugstores grow rapidly The industry estimates that the scale of domestic DTP pharmacy in 2017 is about 13 billion yuan, and the growth rate of DTP pharmacy scale is higher than that of pharmaceutical retail market It is expected that the scale of domestic DTP pharmacy will reach about 19 billion yuan in 2020 In terms of policy support, the outflow of prescription drugs has also become a trend In April 28, 2018, China issued the opinions on promoting the development of Internet plus medical health, and the platform of prescription circulation was the mainstream Recently, Hainan issued the implementation plan of "Internet plus medical health" It will clearly explore the establishment of a unified prescription transfer system in the province, and build a new mode of medical services such as electronic prescriptions for doctors, pharmacists, electronic dispensers, drug retailers, dispensing drugs, delivering drugs to the door or taking medicine conveniently According to the deployment, the prescription circulation information system of Hainan Province will be completed in 2020 Besides Hainan, Guangdong, Gansu, Guangxi, Sichuan, Liaoning, Jiangxi and other provinces and cities also have similar points of "Internet plus medical health" Among them, the circulation platforms in Guangdong, Fujian and other places have been online In general, with the implementation of the volume purchase in China, it is more and more difficult for prescription drugs to enter the hospital, and the outflow of prescription has become a "life-saving straw" for a large number of pharmaceutical enterprises At that time, prescription drugs will also drive the scale growth of retail pharmacies, pharmaceutical enterprises and circulation enterprises.